Member Info for shandypants2

hunky - Star made a loss in both 2018 and 2019 so there was no net profit!!! Gross profit did improve in 2019 but overall loss was slightly higher than 2018.

was in a cineworld this weekend. More staff than customers. Tenet is a poor film too, wouldn't expect that will aid recovery IMHO.

for C+L use code LOVEIT30 to get 30% off first order

struggling to buy any this morning - reckon there is a buyer in background. Can see this moving up ASAP

Duke - H1 will be decent numbers. Jan to March in particular were good and Feb from memory was over £2.5m rev and 50% mining margin when BTC was last at $10k and pre halving. So in Feb alone ARB made £1.25m gross profit c £750k net profit.
Other months weren't so good but net profit made in each up to halving and temporary slow down from mid May.
I'm expecting net profit of minimum £1.5m, hopefully over £2m for H1 2020.

Andy Ross: Franchise Brands
Franchise Brands (LSE: FRAN) is a franchisor. Its franchises include consumer-facing ones such as ChipsAway and Ovenclean as well as business to business ones such as Metro Plumb and Willow Pumps.

I like that management are experienced operators. The executive chairman spent 21 years at Domino’s, which operates a franchise model. A number of the board and other senior management personnel also worked at Domino’s so know the industry well.

It’s an entrepreneurial company which has made acquisitions and retains talent within the business.

Franchisors can make good margins because it’s an asset light business model and I think that bodes well now and in the future.

Andy Ross does not own shares in Franchise Brands.

maybe he means when the price of Brent gets back to $56 a barrel and KRG start paying back some of the money owed to GKP!!

really good update. Share price reaction a little underwhelming. May pick up a little over next few days when results are fully digested. Low PE bodes well and decent divi too

https://www.charlesandlee.co.uk

fill your boots!

well STX presentation from Feb 2020 estimates revenues based on a 5% US market share and conservative market size and royalty estimates is £821m NPV which is £7 a share.
Not only is 5% quite conservative - a 10% market share would equate to £14 a share - but this excludes any revenue from Far East and European markets.
We can dream, or maybe not

https://www.shieldtherapeutics.com/presentations/

great place to be at the moment - some great price movement for the likes of redx, dddd, mtph, 4np recently.

Hopefully we will have our day soon. Keep the faith

more 'mates rates' warrants. I think when i looked at it last year there were c80m warrants at 2p left so i reckon they are maybe 50m left. I may be wrong though, so happy to go with Chesh's figures.
Good spot on the 1.5p too, yes i thought these were all exercised last year.

formality not formulating!!!

its the liquid formula for feraccru - for youngster who can't do pills easily. Should be a formulating but still needs doing and opens up the under 10s market too.

Nice buying ATM and nice to be back in the 1.30s. Was hoping for £1.50 in lead up to US announcement and then hopefully £2 plus afterwards.

H1 2020 numbers also really good despite COVID and Metro Rod going great guns.

Very undervalued IMHO

contract win too in addition to solid H1 results.

All looks good here. Hopefully 70p soon

this share is under the radar so a decent update to accompany H1 should hopefully see this getting back towards 50p

Great H! trading numbers today considering impact of covid. Maybe your £1 prediction will belatedly come true!
Massively undervalued IMHO

recent RNS says cash balance was $144m as at 17th June 2020.

hopefully seller is out . If so hoping back up to 50s soon